Dr. Michael J. Pazzani is Vice President for Research and Economic Development at Rutgers University. His responsibilities at Rutgers include oversight of research and graduate education, external funding for research, laboratory and animal services, and technology commercialization.
Dr. Pazzani is a Professor II of Computer Science at Rutgers, and a member of the Rutgers University Center for Cognitive Science. He also holds a courtesy appointment in Library and Information Science. He has published over 150 papers on machine learning, knowledge discovery from databases, internet search, and recommendation systems. He serves on the Editorial Board of Machine Learning. He is a Fellow of the Association for the Advancement of Artificial Intelligence. He has been funded by the National Science Foundation, the U.S. Department of Education, DARPA, AFOSR, ARO, and several companies including SAIC, Hughes Aircraft, Qualcomm, NYNEX, Websense, and Touchstone Software. He received his Ph.D. in Computer Science from UCLA and was an assistant, associate and full professor at the University of California, Irvine, where he also served as Chair of Information and Computer Science.
Prior to his appointment at Rutgers, Dr. Pazzani was the Director of the Information and Intelligent Systems Division at the National Science Foundation from 2002–2006 where he oversaw a research budget of $200M. In addition, Dr. Pazzani helped to coordinate NSF’s homeland security research. He also served as a member on the Board of Regents of the National Library of Medicine at the National Institutes of Health from 2003–2005.
Dr. Pazzani was a founder and CEO of AdaptiveInfo, a start–up company involved in personalization for the mobile web acquired by Versifi Technologies in 2003. Dr. Pazzani has served on the board of directors of Combichem (NASDAQ: CCHM), a start–up company involved in computational drug discovery that was purchased by DuPont. He was a member of the scientific advisory board of several companies, including Pharsight Corporation (NASDAQ: PHST), a company that enables improvements in the clinical development of therapeutic products, and TripleHop Technologies, Inc that was acquired by Oracle. Dr. Pazzani has served as an expert witness in several patent infringement cases on personalization and internet technology.
To schedule a meeting with me, call Brianne Tysk at 732-932-1500 or email email@example.com. Please make sure you confirm the office where we will meet.